How does Aimovig work to prevent migraines?
Aimovig (erenumab-aooe) works by blocking the receptor of calcitonin gene-related peptide (CGRP) which is thought to contribute to the vasodilation and inflammation associated with migraine.
Aimovig is a fully human monoclonal antibody and is the first in the class of calcitonin gene-related peptide (CGRP) receptor antagonists for migraine prevention.
Aimovig is given once-a-month by subcutaneous (under the skin) self-injections with an auto-injector pen or a single-dose prefilled syringe.
Read next
Related medical questions
- What are the new drugs for the treatment of migraines?
- What is the mechanism of action of Aimovig?
- Can you drink alcohol with Aimovig?
- Can Aimovig cause hair loss (alopecia)?
- How do you use the Aimovig autoinjector?
- Emgality vs Aimovig - how do they compare?
- How long does it take for Aimovig to start working?
- Does Aimovig cause weight gain or loss?
- How is Vyepti different from Aimovig?
- Which medication should I use for migraine headaches?
- How do you inject Aimovig?
- What type of drug is Ajovy?
Drug information
Related support groups
- Aimovig (19 questions, 73 members)
- Erenumab (15 questions, 3 members)
- Migraine (287 questions, 1,620 members)
- Migraine Prevention (123 questions, 335 members)
- Migraine Prophylaxis (70 questions, 82 members)